1-2 of 2
Ian K. McNiece
Close
Sort by
Journal Articles

Myeloablative vs reduced intensity T-cell–replete haploidentical transplantation for hematologic malignancy

Scott R. Solomon, Andrew St. Martin, Nirav N. Shah, Giancarlo Fatobene, Monzr M. Al Malki, Karen K. Ballen, Asad Bashey, Nelli Bejanyan, Javier Bolaños Meade, Claudio G. Brunstein, Zachariah DeFilipp, Richard E. Champlin, Ephraim J. Fuchs, Mehdi Hamadani, Peiman Hematti, Christopher G. Kanakry, Joseph P. McGuirk, Ian K. McNiece, Stefan O. Ciurea, Marcelo C. Pasquini, Vanderson Rocha, Rizwan Romee, Sagar S. Patel, Sumithira Vasu, Edmund K. Waller, John R. Wingard, Mei-Jie Zhang, Mary Eapen
Journal: Blood Advances
Blood Adv (2019) 3 (19): 2836–2844.
https://doi.org/10.1182/bloodadvances.2019000627
Published: 2019
Journal Articles

Related donor transplants: has posttransplantation cyclophosphamide nullified the detrimental effect of HLA mismatch?

Clinical Trials & Observations
Tara M. Robinson, Ephraim J. Fuchs, Mei-Jie Zhang, Andrew St. Martin, Myriam Labopin, Daniel A. Keesler, Didier Blaise, Asad Bashey, Jean-Henri Bourhis, Fabio Ciceri, Stefan O. Ciurea, Steven M. Devine, Mohamad Mohty, Shannon R. McCurdy, Noel Milpied, Ian K. McNiece, Vanderson Rocha, Rizwan Romee, Gerard Socie, Ibrahim Yakoub-Agha, Robert J. Soiffer, Mary Eapen, Arnon Nagler
Journal: Blood Advances
Blood Adv (2018) 2 (11): 1180–1186.
https://doi.org/10.1182/bloodadvances.2018018291
Published: 2018